The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,654.00
Bid: 4,687.00
Ask: 4,691.00
Change: -234.00 (-4.79%)
Spread: 4.00 (0.085%)
Open: 4,683.00
High: 5,004.00
Low: 4,654.00
Prev. Close: 4,888.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme of Arrangement becomes Effective

28 Mar 2018 12:19

RNS Number : 2620J
Plant Impact PLC
28 March 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN EU REGULATION NO. 596/2014 AND IS MADE IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF THAT REGULATION

 

 

28 March 2018

 

RECOMMENDED CASH OFFER

 

for

 

Plant Impact plc

 

by

 

Croda Europe Limited

 

effected by means of a Scheme of Arrangement under

 Part 26 of the Companies Act 2006

 

Scheme of arrangement becomes effective and board changes

 

Further to the announcement of the sanction of the Scheme by the Court on 27 March 2018, the board of directors of Plant Impact plc ("Plant Impact") and the board of directors of Croda Europe Limited ("Croda Europe") are pleased to announce that, following the delivery of an office copy of the Court Order to the Registrar of Companies today, the Scheme has now become Effective, in accordance with its terms, and Plant Impact is now a wholly owned subsidiary of Croda Europe.

 

A Scheme Shareholder on the register of members of Plant Impact at the Scheme Record Time, being 6.00 p.m. on 27 March 2018, will be entitled to receive 10.57 pence in cash for each Scheme Share held. Settlement of the consideration to which any Scheme Shareholder is entitled will be in accordance with the terms of the Scheme. The latest date for the despatch of cheques or the settlement of the consideration in relation to the Offer through CREST is 11 April 2018.

 

Trading in Ordinary Shares on AIM was suspended with effect from 7.30 a.m. today. The admission to trading of the Ordinary Shares on AIM is expected to be cancelled with effect from 7.00 a.m. on 29 March 2018. A further announcement will be made when the admission to listing and to trading of the Ordinary Shares on AIM have each been cancelled.

 

As a result of the Scheme having become Effective, share certificates in respect of Ordinary Shares have ceased to be valid documents of title and entitlements to Ordinary Shares held in uncertificated form in CREST will be cancelled.

 

Defined terms used but not defined in this announcement have the meaning given to them in the scheme circular to Plant Impact Shareholders dated 26 February 2018. References to time in this announcement are references to the time in London, the United Kingdom.

 

Board and officer changes

 

As the Scheme has now become Effective:

 

· David Jones, Christopher Tyler and John Brubaker have resigned as directors of Plant Impact;

 

· Ib Jensen has resigned as Plant Impact's company secretary;

 

· David Cherry, Nick Challoner and Graham Myers have been appointed as directors of Plant Impact; and

 

· Thomas Michael Brophy has been appointed as Plant Impact's company secretary,

 

in each case, with immediate effect.

 

Enquiries:

Croda Europe

Tel: +44 (0) 140 586 0551

Conleth Campbell

 

 

GCA Altium, financial adviser to Croda Europe

 

Tel: +44 (0) 845 505 4300

Phil Adams

 

Paul Lines

 

 

Teneo Blue Rubicon, public relations adviser to Croda Europe

 

Tel: +44 (0) 203 603 5220

Charlie Armitstead

 

 

 

Plant Impact

Tel: +44 (0) 158 246 5540

Ailish Tracy

 

Peel Hunt, Rule 3 adviser to Plant Impact

 

 

Tel: +44 (0) 207 418 8900

Adrian Trimmings

 

Michael Nicholson

 

George Sellar

 

Nicole McDougall

 

 

Buchanan, public relations adviser to Plant Impact

Tel: +44 (0) 207 466 5000

Mark Court

 

Sophie Wills

 

Jamie Hooper

 

 

IMPORTANT NOTICES

GCA Altium, which is authorised and regulated in the UK by the Financial Conduct Authority, is acting exclusively for Croda Europe and no one else in connection with the matters set out in this announcement. In connection with such matters, GCA Altium will not regard any other person as its client, nor will it be responsible to any other person for providing the protections afforded to clients of GCA Altium or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

Peel Hunt, which is authorised and regulated in the UK by the Financial Conduct Authority, is acting exclusively for the Plant Impact and no one else in connection with the matters set out in this announcement. In connection with such matters, Peel Hunt will not regard any other person as its client, nor will it be responsible to any other person for providing the protections afforded to clients of Peel Hunt or for providing advice in relation to any matter referred to herein.

Neither Peel Hunt nor any of its subsidiaries, affiliates or branches owes or accepts any duty, liability or responsibility whatsoever (whether direct, indirect, consequential, whether in contract, in tort, under statute or otherwise) to any person who is not a client in connection with this announcement, any statement contained herein or otherwise.

Publication on Website(s) and Availability of Hard Copies

A copy of this announcement will be available free of charge (subject to any applicable restrictions with respect to persons resident in Restricted Jurisdictions) on Plant Impact's website and Croda's website (http://www.plantimpact.com/investors and https://www.croda.com/en-gb/investors respectively) by no later than 12 noon on the Business Day following the date of this announcement.

Neither the contents of these websites nor the content of any other website accessible from hyperlinks on such websites is incorporated into, or forms part of, this announcement.

You may request a hard copy of this announcement (and any information incorporated by reference in this announcement), free of charge, by contacting Peel Hunt during business hours on +44(0)20 7418 8900 or by submitting a request in writing to Peel Hunt at Moor House, 120 London Wall, EC2Y 5ET. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. Lines will be open between 9.00 a.m. to 5.00 p.m., Monday to Friday excluding public holidays in England and Wales. Unless you make such a request, a hard copy of this announcement and any such information incorporated by reference in it will not be sent to you. You may also request that all future documents, announcements and information to be sent to you in relation to the Offer be in hard copy form. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFVLFLVXFFBBD
Date   Source Headline
24th Apr 20247:00 amRNSFirst quarter 2024 sales update
11th Apr 20242:11 pmRNSDirector/PDMR Shareholding
8th Apr 202410:54 amRNSDirector/PDMR Shareholding
8th Apr 202410:23 amRNSDirector/PDMR Shareholding
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding
12th Jun 20232:06 pmRNSDirector/PDMR Shareholding
9th Jun 20237:00 amRNSTrading update
31st May 20232:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.